Prothrombotic state, endothelial injury, and echocardiographic changes in non-active sarcoidosis patients

• Published in: Scientific reports 2022-12, Vol.12 (1), p.21291-21291, Article 21291
• Main Authors: Siwiec-Kozlik, Andzelika, Kuszmiersz, Piotr, Kasper, Lukasz, Frolow, Marzena, Kozlik-Siwiec, Pawel, Iwaniec, Teresa, Kosalka-Wegiel, Joanna, Zareba, Lech, Sladek, Krzysztof, Bazan, Jan G., Bazan-Socha, Stanislawa, Dropinski, Jerzy
• Format: Article
• Language: English
• Subjects: 631/250/2500; 631/250/256; 692/308; 692/699/1785; 692/700/139/1420; 692/700/1421/1860/1445; Biomarkers; Cardiovascular diseases; Cell adhesion molecules; Coagulation factors; Corticoids; Corticosteroids; Diastole; Echocardiography; Epidemiology; Health risks; Heart; Humanities and Social Sciences; Humans; Hypercalcemia; Lungs; Lymph nodes; multidisciplinary; Remission; Remission (Medicine); Respiratory function; Sarcoidosis; Sarcoidosis - diagnostic imaging; Science; Science (multidisciplinary); Systole; Thrombin; Thrombin - metabolism; Vascular cell adhesion molecule 1; Ventricle
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-25580-w

Sarcoidosis is a multisystem inflammatory granulomatous disease of unknown cause that most commonly affects lungs and lymph nodes, with frequent yet asymptomatic cardiac involvement. The epidemiologically associated cardiovascular risk suggests an underlying prothrombotic state and endothelial dysfunction, currently understudied in the available literature. Therefore, we aimed to investigate prothrombotic plasma properties together with selected echocardiographic and laboratory biomarkers of cardiovascular injury in that disease. N = 53 patients with pulmonary sarcoidosis in clinical remission and N = 66 matched controls were assessed for inflammatory and endothelial injury biomarkers, plasma thrombin generation profile, and echocardiographic and lung function parameters. Sarcoidosis cases had impaired systolic and diastolic left ventricular function, higher concentrations of inflammatory markers, D-dimer and factor VIII activity compared to the controls. The coexistence of extrapulmonary disease was associated with elevated circulating vascular cell adhesion molecule 1, while cases with hypercalcemia had higher thrombomodulin concentration. Sarcoidosis was characterized by the unfavorably altered thrombin generation profile, reflected by the 16% higher endogenous thrombin potential (ETP), 24% increased peak thrombin concentration, and 12% shorter time to thrombin peak in comparison to the control group. ETP was higher in cases with proxies of pulmonary restriction, extrapulmonary–extracutaneous manifestation, and need for corticosteroids use. Despite the clinical remission, sarcoidosis is related to prothrombotic plasma properties and signs of endothelial injury, likely contributing to the higher risk of cardiovascular events. In addition, subclinical cardiac involvement may play an additional role, although further clinical and experimental studies are needed to verify these findings.